News Celltrion hopes to outdo inflammatory disease rivals with SC... Drugmaker could file in EU in coming weeks, according to report
Partner Content Partner Content FDA releases Biosimilar Action Plan: Hear more at Biosimilar... Biosimilars USA conference information
News FDA approves second Neupogen biosimilar Already facing competition from Sandoz, Amgen’s Neupogen white blood cell stimulator faces another cut-price near-copy after the FDA approved Pfizer’s biosimilar, Nivestym.
Market Access Biosimilar switches and healthcare gains Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery among those outside the sector.
Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Events Partner Content SMi's 5th Annual Biosimilars USA Conference Biosimilars USA conference information
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
